Seven Oncologists Charged with Importing Unapproved Drugs

August 13, 2013: Seven Oncologists Charged with Importing Unapproved Drugs - U.S. Department of Justice Press Release

 

Seven Ohio oncologists were charged with importing cancer medications that had not been approved by the Food and Drug Administration, said Steven M. Dettelbach, United States Attorney for the Northern District of Ohio.

 

The doctors were charged with causing the shipment of misbranded drugs, a misdemeanor violation of the Food, Drug and Cosmetic Act. Their names, ages and the city where they practiced medicine are:

 

Ranjan Bhandari, 56, Liverpool.

Timmappa Bidari, 68, Parma.

David Fishman, 62, Euclid.

Su-Chiao Kuo, 60, Brunswick.

Marwan Massouh, 54, Westlake.

Poornanand Palaparty, 62, Cleveland.

Hassan Tahsildar, 55, Euclid

 

"These doctors used drugs that had not been approved by the FDA," Dettelbach said. "Our office is committed to working with our partners to make sure patients are getting medicine that has been properly inspected."

 

"FDA's regulatory standards are designed to ensure the safety and quality of the medical devices and drugs distributed to American consumers," said Antoinette V. Henry, Special Agent in Charge, FDA's Office of Criminal Investigations. "We will continue to work to investigate all persons, including medical professionals, who disregard regulatory requirements and jeopardize the public health by participating in the distribution of misbranded products."

 

The doctors are accused of obtaining drugs, including Zometa, Kytril, Taxotere, Gemzar, Eloxatin and others, from outside the United States, where the drugs were not approved by the FDA, according to the charges.

Read more: Seven Oncologists Charged with Importing Unapproved Drugs - FiercePharma Manufacturing http://www.fiercepharmamanufacturing.com/press-releases/seven-oncologists-charged-importing-unapproved-drugs#ixzz2dGoFL7Rp 
Subscribe at FiercePharma Manufacturing